Home

EVM is a specialised group within the European Federation of Pharmaceutical Industries and Associations (EFPIA), the professional association of the European pharmaceutical industry.

Formed in 1991 to improve public health through immunization and promoting R&D of innovative vaccines, EVM represents major European vaccine producers accounting for the majority of the vaccines used worldwide.

EVM Members are dedicated to improve public health through immunization and to promote R&D of innovative vaccines.

>> More about EVM

NEWS

Manufacturers ready to help combat the threat posed by both seasonal and pandemic influenza - 24 June 2009

---

H1N1 vaccines frequently askded questions - 24 June 2009

---

EVM statement regarding WHO decision to declare global influenza pandemic - "EVM Members" prepared to play their role to fight against the pandemic influenza threat - 11 June 2009

---

EVM statement on meeting with the European Medicines Agency to prepare regulatory strategy for approval of vaccines against novel H1N1 strain - 30 April 2009

---

European Medicines Agency prepares for approval of pandemic vaccines - 30 April 2009

---

EVM statement on meeting with Commissioner Vassiliou regarding novel influenza virus - 29 April 2009

---

Commissioner Vassiliou’s meeting with the European Vaccine Manufacturers - European Commission Press release - 29 April 2009

---

EVM Statement regarding Swine Infuenza outbreak - 28 April 2009

EVENTS

[No recent event]